№ files_lp_3_process_9_64871
File format: docx
Character count: 5300
File size: 24 KB
Reference guide listing official materials, technical documentation, reporting forms, validation rules, and revision history associated with implementation of the RVCT 2020 Message Mapping Guide for tuberculosis case notification within the national surveillance system.
Year:
2019–2020
Organization:
Centers for Disease Control and Prevention
Program:
National Notifiable Diseases Surveillance System (NNDSS)
Related Initiative:
NMI Technical Assistance and Training Resource Center
Subject:
Tuberculosis (TB) and Latent TB Infection (LTBI) Reporting
Document Type:
Reference materials listing and resource guide
Associated Forms:
RVCT Reporting Form (Final), TBLISS Reporting Form (Final), MDR Supplemental Information Form
Version References:
Generic v2.0 MMG; Tuberculosis and Latent TB Infection v3.0 MMG
Release Dates Referenced:
2019-10-16; 2019-10-29; 2020-01-08; 2020-01-09
Technical Resources:
Validation Rules, Inconsistent Data Rules, MUNK Rules, Data Element Comparison Spreadsheet
Contact Information:
[email protected]
FTP Location:
ftp://ftp.cdc.gov/pub/Software/TIMS/2020%20RVCT%20Documentation/
Intended Audience:
Public health program staff, surveillance personnel, and software developers implementing MMG specifications
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2019–2020
Topic:
Tuberculosis case reporting and surveillance
Document type:
Reference materials listing and documentation index
Program:
RVCT 2020
Related guides:
Message Mapping Guides (MMG)
Institutions:
Centers for Disease Control and Prevention; NNDSS; DTBE; CSELS
Associated conditions:
Tuberculosis; Latent Tuberculosis Infection
Formats referenced:
DOCX; XLSX; FTP resources; web resources
Revision period:
October 2019 – January 2020
Contact information:
[email protected]
Source type:
Technical and administrative public health documentation
Year:
2020
Region / City:
United States
Topic:
Tuberculosis Surveillance
Document Type:
Instruction Manual
Organization / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
Not specified
Target Audience:
Public health professionals, TB control programs
Effective Period:
Ongoing
Approval Date:
November 2019
Date of Changes:
None specified
Year:
2022
Region / City:
United States
Topic:
Tuberculosis Case Reporting
Document Type:
Report
Organ / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
Centers for Disease Control and Prevention (CDC)
Target Audience:
Healthcare professionals, public health officials
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2019
Region/City:
United States
Topic:
Tuberculosis Reporting and Evaluation
Document Type:
Data Collection Form
Agency/Institution:
Centers for Disease Control and Prevention (CDC)
Author:
Centers for Disease Control and Prevention
Target Audience:
Public Health Officials, Healthcare Providers
Effective Period:
Ongoing
Approval Date:
10/29/2019
Date of Changes:
Not specified
Agency:
United States Securities and Exchange Commission
Form number:
Form 25
Document type:
Regulatory filing form
Jurisdiction:
United States
Legal basis:
Securities Exchange Act of 1934
Applicable rules:
Rule 12d2-2 (17 CFR 240.12d2-2); Rule 19d-1 (17 CFR 240.19d-1)
OMB control number:
3235-0080
OMB expiration date:
March 31, 2021
Filing system:
EDGAR
Effective delisting period:
10 days after filing
Effective withdrawal of registration period:
90 days after filing
Revision identifier:
SEC 1654 (03-06)
Year:
2025
Region / city:
Australia
Subject:
Oncology, Pharmaceutical Submission
Document Type:
Pharmaceutical Benefits Scheme (PBS) Submission
Organ / Institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
JANSSEN-CILAG PTY LTD
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing
Approval Date:
Pending
Date of modifications:
N/A
Year:
2025
Region / City:
Uganda
Theme:
Procurement, Health Services, Public Contracts
Document Type:
Pre-Qualification Notice
Authority:
Mulago Specialised Women and Neonatal Hospital
Author:
Not specified
Target Audience:
Providers, Contractors, Suppliers
Period of Validity:
2025-2028
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2024
Region / Country:
Australia
Therapeutic Area:
Gastroenterology
Type of Document:
Regulatory submission / PBAC evaluation
Product:
Budesonide 4 mg suppository (Budenofalk®)
Comparator:
Budesonide 2 mg foam (Budenofalk®), prednisolone suppositories and enemas, hydrocortisone acetate enemas
Regulatory Authority:
TGA (Therapeutic Goods Administration)
Intended Use:
Short-term treatment of mild to moderate ulcerative colitis limited to the rectum
Prescriber Type:
Medical practitioners, Nurse practitioners
PBS Benefit Type:
Unrestricted
Maximum Quantity:
1 pack, 30 units
Treatment Duration:
up to 8 weeks per script
Clinical Evidence:
Phase 3, randomized, double-blind, double-dummy, non-inferiority trial (BUS-4/UCA)
Year:
2025
Region / City:
Windhoek
Subject:
Public Administration, Consultancy, Research
Document Type:
Official Announcement
Institution:
Namibia Institute of Public Administration and Management (NIPAM)
Author:
NIPAM
Target Audience:
Facilitators, Researchers, Consultants, Public Sector Experts
Period of Validity:
Until 10 February 2025
Approval Date:
Not specified
Date of Last Modification:
Not specified
Year:
2011
Regulation:
The Companies Regulations 2011, as amended
Region / Market:
Johannesburg Stock Exchange (JSE)
Document Type:
Regulatory guidance / compliance document
Scope:
Pre-Listing Statements (PLS), Revised Listing Particulars (RLP), Circulars
Language:
English
Applicable Parties:
Issuers and applicants seeking listing on JSE
Requirements:
Disclosure obligations, material contracts, corporate actions
Website Obligation:
Operational website for disclosure compliance
Audience:
Investors, shareholders
Year:
[Year]
Region / City:
Wellington
Topic:
Securities listing and quotation
Document Type:
Application
Organization:
NZ RegCo
Author:
[Issuer Name]
Target Audience:
NZX, securities issuers
Effective Period:
[Date]
Approval Date:
[Date]
Amendment Date:
[Date]
Year:
2023
Region / city:
Australia
Topic:
Oncology, Pharmaceuticals
Document Type:
Resubmission
Institution:
Australian Government, Pharmaceutical Benefits Advisory Committee
Author:
AstraZeneca Pty Ltd.
Target Audience:
Healthcare professionals, regulatory bodies
Effective Period:
Ongoing
Approval Date:
November 2021
Date of Changes:
November 2021
Note:
Year
Note:
Year
Year:
2021
Region / city:
United States
Subject:
COVID-19, Federal Audit Clearinghouse
Document Type:
Memo
Institution:
Department of Education
Author:
Phillip Juengst, Deputy Assistant Secretary
Target Audience:
Grant recipients of the Department of Education
Effective Date:
August 9, 2021
Date of Approval:
August 4, 2021
Questions:
[email protected]
Period of Applicability:
For single audit submissions on or after August 9, 2021
Document Description:
Guidance on how to report subprogram Assistance Listing Numbers (ALNs) with their alphas in the Federal Audit Clearinghouse single audit submission form for Department of Education programs.
Year:
2021
Region / city:
South Africa
Topic:
Financial Instruments, Exchange-Traded Notes
Document Type:
Listing Announcement
Organ / Institution:
FirstRand Bank Limited
Author:
FirstRand Bank Limited
Target Audience:
Investors, Financial Institutions
Period of Validity:
17 August 2021 – 17 August 2026
Approval Date:
17 August 2021
Amendment Date:
None
Year:
2018
Region / city:
Australia
Topic:
Immunisation, Hepatitis B
Document type:
Report
Agency / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Chief Medical Officer
Target audience:
Healthcare professionals, policymakers
Period of validity:
Until 31 December 2019
Date of approval:
June 2018
Date of amendments:
None
Year:
2021
Event:
Expert meeting
Location:
Online
Organization:
UNESCO
Topic:
Intangible cultural heritage, listing mechanisms
Type of document:
Report / Meeting overview
Author:
Rieks Smeets
Target audience:
UNESCO member states, cultural heritage experts
Dates of event:
26–27 May 2021
Time:
13:00–16:00 (Paris time / UTC+2)
Historical period covered:
1960s–2008
Year:
2021
Region / city:
Online
Subject:
Intangible Cultural Heritage
Document type:
Background Paper
Organization:
UNESCO
Author:
UNESCO Secretariat
Target audience:
Experts, States Parties, practitioners in the field of intangible cultural heritage
Duration:
May 2021 – ongoing
Approval date:
Not provided
Amendment date:
Not provided
Year:
December 2025
Region / City:
Australia
Topic:
Information Security, Cloud Security
Document Type:
Template
Organization / Institution:
Australian Signals Directorate (ASD)
Author:
Unknown
Effective Period:
Ongoing
Approval Date:
December 2025
Date of Changes:
N/A